Asthma, asthma treatment, biologics, biomarkers, interleukins Subgroups of adolescent and adult patients with elevated type 2 biomarkers (blood eosinophils >=150 cells/µL or FeNO >=20 ppb) at baseline were also examined post hoc. Keywords: asthma; asthma treatment; biologics; biomarkers; interleukins EN asthma asthma treatment biologics biomarkers interleukins 2621 2624 4 07/19/21 20210801 NES 210801 ACKNOWLEDGMENTS Critical input on the concept was provided by Heribert Staudinger, MD. [Extracted from the article]